DCP Capital to invest in Venus Medtech
DCP Capital has agreed to invest in Venus Medtech. Financial terms weren’t announced. Venus Medtech, of Hangzhou, China, develops heart valves. Haoyue Capital provided financial advice.
16 May 2018•4 mins read
DCP Capital has agreed to invest in Venus Medtech. Financial terms weren’t announced. Venus Medtech, of Hangzhou, China, develops heart valves. Haoyue Capital provided financial advice.
Paradigm Equity Partners acquires upholstery and performance fabric maker STI Fabrics
6 hours ago · 1 min read
KKR and Hildred merge diagnostics businesses Sapphiros and binx health into Onvaro
6 hours ago · 2 mins read
Eir Partners-backed Porter acquires health plan analytics firm Pareto Intelligence
6 hours ago · 1 min read
Bain Capital’s LeanTaaS snaps up hospital care transition platform Aidin
6 hours ago · 2 mins read
Carlyle-backed Vantive agrees hemodialysis business sale to Rockwell Medical
6 hours ago · 2 mins read
Novacap completes OSI Maritime Systems acquisition as first Fund VII deal
7 hours ago · 2 mins read
Long Arc-backed Robertson Stephens adds Denver adviser Altius Financial
7 hours ago · 1 min read
